Ossur hf
CSE:OSSR
Intrinsic Value
Össur hf is a global orthopaedics company, which engages in the design, development, manufacture, and sale of non-invasive orthopedic products. [ Read More ]
The intrinsic value of one OSSR stock under the Base Case scenario is 36.74 DKK. Compared to the current market price of 29.5 DKK, Ossur hf is Undervalued by 20%.
Valuation Backtest
Ossur hf
Run backtest to discover the historical profit from buying and selling OSSR stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Ossur hf
Current Assets | 376m |
Cash & Short-Term Investments | 72.7m |
Receivables | 127.8m |
Other Current Assets | 175.5m |
Non-Current Assets | 1B |
Long-Term Investments | 25.1m |
PP&E | 186.1m |
Intangibles | 756.7m |
Other Non-Current Assets | 41.9m |
Current Liabilities | 196.2m |
Accounts Payable | 30.7m |
Accrued Liabilities | 50.1m |
Other Current Liabilities | 115.4m |
Non-Current Liabilities | 487.6m |
Long-Term Debt | 424.4m |
Other Non-Current Liabilities | 63.2m |
Earnings Waterfall
Ossur hf
Revenue
|
785.7m
USD
|
Cost of Revenue
|
-300.1m
USD
|
Gross Profit
|
485.6m
USD
|
Operating Expenses
|
-396.2m
USD
|
Operating Income
|
89.4m
USD
|
Other Expenses
|
-31m
USD
|
Net Income
|
58.4m
USD
|
Free Cash Flow Analysis
Ossur hf
OSSR Profitability Score
Profitability Due Diligence
Ossur hf's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Ossur hf's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
OSSR Solvency Score
Solvency Due Diligence
Ossur hf's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Score
Ossur hf's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
OSSR Price Targets Summary
Ossur hf
According to Wall Street analysts, the average 1-year price target for OSSR is 35.65 DKK with a low forecast of 32.32 DKK and a high forecast of 40.95 DKK.
Shareholder Return
OSSR Price
Ossur hf
Average Annual Return | -1.5% |
Standard Deviation of Annual Returns | 26.11% |
Max Drawdown | -54% |
Market Capitalization | 12.4B DKK |
Shares Outstanding | 426 934 475 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Össur hf is a global orthopaedics company, which engages in the design, development, manufacture, and sale of non-invasive orthopedic products. The firm is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The firm is divided into three market segments: Bracing and Supports, which offers products for therapeutic and preventive purposes; Prosthetics, which offers products for amputees, which include sockets, sleeves, prosthetic knees and feet, as well as supporting components, and Compression Therapy, which offers treatment for venous ulcers and edema. The firm's main markets are North America, Europe and Asia. The company has subsidiaries in Iceland, the United States, Canada, Mexico, France, the Netherlands, the United Kingdom, Sweden, Norway, Spain, South Africa, China and Australia.
Contact
IPO
Employees
Officers
The intrinsic value of one OSSR stock under the Base Case scenario is 36.74 DKK.
Compared to the current market price of 29.5 DKK, Ossur hf is Undervalued by 20%.